Febit Restructures to Concentrate on miRNA Biomarkers

As a result of the restructuring, its workforce has been reduced by 60 percent and its CEO and President has left the company.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories